Your session is about to expire
← Back to Search
MSCs Dose Level 0 into one submandibular gland for Graft-versus-Host Disease
Study Summary
This trial aims to test if injecting a type of cells called mesenchymal stromal cells (MSCs), produced in your bone marrow, into your salivary glands can help improve dry
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are new participants currently being welcomed to enroll in this trial?
"As per the data available on clinicaltrials.gov, recruitment for this specific trial is not ongoing. The study was first listed on May 1st, 2024 and last modified on April 25th, 2024. However, amidst the inactive status of this trial, it's noteworthy that there are currently 221 other trials actively seeking patient participation."
Is there an age restriction for participants to be considered in this study?
"Individuals aged 18 years or older, but under the age of 90, are eligible for enrollment in this study."
Is the administration of MSCs at Dose Level 0 into a single submandibular gland approved by the FDA?
"Our team at Power rates the safety of MSCs Dose Level 0 administration into a single submandibular gland as 1 due to the preliminary nature of this Phase I trial, indicating limited available data on both safety and efficacy."
Share this study with friends
Copy Link
Messenger